OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(23)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2021
(1)
CHEBI ID
CHEBI:24835
(1)
CHEBI:48591
(1)
CHEBI:39270
(1)
CHEBI:24059
(1)
CHEBI:50917
(1)
CHEBI:24402
(1)
CHEBI:32955
(1)
CHEBI:36735
(1)
CHEBI:38776
(1)
CHEBI:59659
(1)
CHEBI:38193
(1)
CHEBI:25340
(1)
CHEBI:33833
(1)
CHEBI:48835
(1)
CHEBI:77383
(1)
CHEBI:38670
(1)
CHEBI:37739
(1)
CHEBI:38314
(1)
CHEBI:38093
(1)
CHEBI:24955; CHEBI:52898
(1)
CHEBI:38976; CHEBI:36820
(1)
CHEBI:38669
(1)
CHEBI:48588
(1)
CHEBI:47985
(1)
CHEBI:23245
(1)
CHEBI:39307
(1)
CHEBI:26767
(1)
CHEBI:24436
(1)
CHEBI:22715; CHEBI:35813
(1)
CHEBI:48436
(1)
Metabolite Name
Cycloartanols and derivatives
(1)
Miscellaneous mixed metal/non-metals
(1)
N-acylpiperidines
(1)
Naphthofurans
(1)
Fluorenes
(1)
Oxasteroids and derivatives
(1)
Galanthamine-type amaryllidaceae alkaloids
(1)
Glycosphingolipids
(1)
Aristolactams
(1)
Oxirane carboxylic acids and derivatives
(1)
Bilirubins
(1)
Imidazoquinolines
(1)
Pyrenes
(1)
Phenylpyridines
(1)
Organic nitro compounds
(1)
Methylpyridines
(1)
Heteroaromatic compounds
(1)
Phenanthrolines
(1)
Bisphosphonates
(1)
Phosphonic acid esters
(1)
Pyrrolo[2,3-d]pyrimidines
(1)
Glycerophospholipids
(1)
Pyrazines
(1)
Phenylacetylindoles
(1)
Phenothiazines
(1)
Macrolactams
(1)
Cyclohexylphenols
(1)
Pyrazolo[1,5-a]pyrimidines
(1)
Peptoid-peptide hybrids
(1)
Aminopiperidines
(1)
Release Date
2023
(6)
2022
(6)
2024
(5)
2025
(4)
2026
(1)
2021
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer.
Not available
S-EPMC10679971
|
biostudies-literature
Cite
TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression.
Not available
S-EPMC9980475
|
biostudies-literature
Cite
Destabilization of microrchidia family CW-type zinc finger 2 via the cyclin-dependent kinase 1-chaperone-mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule-targeting agents.
Not available
S-EPMC10040724
|
biostudies-literature
Cite
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Not available
S-EPMC10990288
|
biostudies-literature
Cite
Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.
Not available
S-EPMC9896024
|
biostudies-literature
Cite
MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.
Not available
S-EPMC12442607
|
biostudies-literature
Cite
Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study.
Not available
S-EPMC10389616
|
biostudies-literature
Cite
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
Not available
S-EPMC9485257
|
biostudies-literature
Cite
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer.
Not available
S-EPMC9061756
|
biostudies-literature
Cite
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.
Not available
S-EPMC8951705
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
